Contents:

-1 U.S. HUMAN GROWTH HORMONE MARKET --Overview ---Title ---Disclaimer and Certification ---Table of Contents ---Notes on Methodology --Market Introduction ---Market Introduction ---Human Growth Hormone: Definition ---Human Growth Hormone Market: Market Overview ---Product Analysis ---Competitive Structure --Disease Overview and Drug Delivery Systems ---Disease Overview and Drug Delivery Systems ---FDA Approved Indications ---Disease Overview ---Therapy Guidelines ---Pediatric Human Growth Hormone Market ---Adult Human Growth Hormone Market ---Drug Delivery Systems --New Indications and Challenges ---Idiopathic Short Stature ---Small for Gestational Age --Hot Topics ---Hot Topics ---The Debate on Bio-generics ---Product Off-label and Investigational Uses ---Debate on Off-label Use of Growth Hormone --Market Trends ---Market Trends ---Industry Challenges ---Market Drivers ---Market Restraints --Revenue Analysis ---Revenue Analysis ---Market Engineering Measurements ---Patient Forecast ---Therapy Cost and Treatment Patterns ---Annual Treatment Costs Forecast ---Revenue Forecasts --Market Share Analysis ---Market Share Analysis ---Company Market Share ---Market Share Discussion --Clinical Developments and Pipeline ---Clinical Developments and Pipeline ---Clinical Developments ---Ongoing Clinical Trials for Marketed Products --Company Profiles ---Company Profiles ---Genentech ---Eli Lilly ---Pfizer ---Novo Nordisk ---EMD Serono ---Teva Pharmaceuticals ---Sandoz --Conclusion ---Conclusion ---Future Competitive Landscape --About Frost & Sullivan ---Frost & Sullivan

Companies Mentioned

Genentech Eli Lilly Pfizer Novo Nordisk EMD Serono Teva Pharmaceuticals Sandoz